KALA logo

Kala Pharmaceuticals (KALA) Working Capital

Annual Working Capital

$44.52 M
-$15.73 M-26.11%

December 31, 2023


Summary


Performance

KALA Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKALAbalance sheetmetrics:

Quarterly Working Capital

$27.41 M
-$12.25 M-30.89%

September 30, 2024


Summary


Performance

KALA Quarterly Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKALAbalance sheetmetrics:

Working Capital Formula

Working Capital = Current Assets − Current Liabilities

KALA Working Capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-26.1%-42.4%
3 y3 years-70.2%-54.5%
5 y5 years-72.2%-54.5%

KALA Working Capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-48.8%at low-68.5%at low
5 y5-year-70.2%at low-85.8%at low
alltimeall time-72.2%+2026.3%-85.8%+36.8%

Kala Pharmaceuticals Working Capital History

DateAnnualQuarterly
Sep 2024
-
$27.41 M(-30.9%)
Jun 2024
-
$39.66 M(+3.8%)
Mar 2024
-
$38.21 M(-14.2%)
Dec 2023
$44.52 M(-26.1%)
$44.52 M(-6.5%)
Sep 2023
-
$47.60 M(-14.5%)
Jun 2023
-
$55.68 M(-8.8%)
Mar 2023
-
$61.08 M(+1.4%)
Dec 2022
$60.26 M(-30.7%)
$60.26 M(+35.6%)
Sep 2022
-
$44.43 M(-12.2%)
Jun 2022
-
$50.62 M(-22.7%)
Mar 2022
-
$65.50 M(-24.7%)
Dec 2021
$86.94 M(-41.7%)
$86.94 M(-28.7%)
Sep 2021
-
$121.89 M(-16.3%)
Jun 2021
-
$145.64 M(-8.4%)
Mar 2021
-
$159.08 M(+6.7%)
Dec 2020
$149.15 M
$149.15 M(-6.0%)
DateAnnualQuarterly
Sep 2020
-
$158.61 M(-11.9%)
Jun 2020
-
$180.08 M(-6.7%)
Mar 2020
-
$192.97 M(+139.1%)
Dec 2019
$80.71 M(-49.6%)
$80.71 M(-14.6%)
Sep 2019
-
$94.49 M(-17.9%)
Jun 2019
-
$115.10 M(-15.3%)
Mar 2019
-
$135.85 M(-15.1%)
Dec 2018
$160.02 M(+59.5%)
$160.02 M(+136.1%)
Sep 2018
-
$67.77 M(-17.9%)
Jun 2018
-
$82.54 M(-14.4%)
Mar 2018
-
$96.44 M(-3.9%)
Dec 2017
$100.34 M(+150.4%)
$100.34 M(-10.2%)
Sep 2017
-
$111.75 M(+457.5%)
Jun 2017
-
$20.04 M(-33.4%)
Mar 2017
-
$30.09 M(-24.9%)
Dec 2016
$40.08 M(+1814.0%)
$40.08 M
Dec 2015
$2.09 M
-

FAQ

  • What is Kala Pharmaceuticals annual working capital?
  • What is the all time high annual working capital for Kala Pharmaceuticals?
  • What is Kala Pharmaceuticals annual working capital year-on-year change?
  • What is Kala Pharmaceuticals quarterly working capital?
  • What is the all time high quarterly working capital for Kala Pharmaceuticals?
  • What is Kala Pharmaceuticals quarterly working capital year-on-year change?

What is Kala Pharmaceuticals annual working capital?

The current annual working capital of KALA is $44.52 M

What is the all time high annual working capital for Kala Pharmaceuticals?

Kala Pharmaceuticals all-time high annual working capital is $160.02 M

What is Kala Pharmaceuticals annual working capital year-on-year change?

Over the past year, KALA annual working capital has changed by -$15.73 M (-26.11%)

What is Kala Pharmaceuticals quarterly working capital?

The current quarterly working capital of KALA is $27.41 M

What is the all time high quarterly working capital for Kala Pharmaceuticals?

Kala Pharmaceuticals all-time high quarterly working capital is $192.97 M

What is Kala Pharmaceuticals quarterly working capital year-on-year change?

Over the past year, KALA quarterly working capital has changed by -$20.19 M (-42.41%)